Ritalin LA 20 mg/1
methylphenidate hydrochloride · CAPSULE, EXTENDED RELEASE · Novartis Pharmaceuticals Corporation
Ritalin LA is a capsule, extended release containing methylphenidate hydrochloride at 20 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Ritalin LA
- Generic Name
- methylphenidate hydrochloride
- NDC Code (Product)
0078-0370- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 20 mg/1
- Dosage Form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA021284
- Marketing Start
- 06/05/2002
Recall History
No Recall HistoryFrequently Asked Questions
What is Ritalin LA used for?
Ritalin LA contains methylphenidate hydrochloride. It is a capsule, extended release taken oral. Consult your doctor for specific uses.
Is Ritalin LA a controlled substance?
Yes, Ritalin LA is classified as CII under the DEA Controlled Substances Act.
What is the generic name for Ritalin LA?
The generic name for Ritalin LA is methylphenidate hydrochloride. There are 12 other brand versions of methylphenidate hydrochloride.
What is the NDC code for Ritalin LA 20 mg/1?
The NDC (National Drug Code) for Ritalin LA 20 mg/1 is 0078-0370, listed by Novartis Pharmaceuticals Corporation.
Other Methylphenidate Brands
See all →- Methylphenidate Hydrochloride5 mg/5mL72162-1992
- Methylphenidate Hydrochloride27 mg/172162-2395
- Methylphenidate Hydrochloride54 mg/10527-3313
- METHYLPHENIDATE HYDROCHLORIDE5 mg/116729-478
- QuilliChew ER40 mg/124478-076
- Methylphenidate Hydrochloride5 mg/143386-571
- Methylphenidate Hydrochloride5 mg/5mL43386-930
- Methylphenidate Hydrochloride27 mg/150268-546
- Methylphenidate Hydrochloride10 mg/155466-102
- Methylphenidate Hydrochloride5 mg/164980-222
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)